Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• Morgan Stanley analyst Drew Ranieri upgraded the rating for Stryker Corporation SYK from Equal-Weight to Overweight and raised the price target from $370 to $445. Stryker shares closed at $392.15 on Friday. See how other analysts view this stock.
• Oppenheimer analyst Timothy Horan upgraded Akamai Technologies, Inc. AKAM from Perform to Outperform and announced a $120 price target. Akamai Techs shares closed at $94.02 on Friday. See how other analysts view this stock.
• JP Morgan analyst Matthew Boss upgraded the rating for The Gap, Inc. GAP from Neutral to Overweight and boosted the price target from $28 to $30. Gap shares closed at $24.25 on Friday. See how other analysts view this stock.
• Evercore ISI Group analyst Vijay Kumar upgraded NovoCure Limited NVCR from In-Line to Outperform and raised the price target from $18 to $30. NovoCure shares closed at $20.04 on Friday. See how other analysts view this stock.
• TD Cowen analyst Bryan Bergin upgraded the rating for Paycor HCM, Inc. PYCR from Hold to Buy and increased the price target from $18 to $22. Paycor HCM shares closed at $18.06 on Tuesday. See how other analysts view this stock.

Considering buying GAP stock? Here’s what analysts think:

Read This Next: